Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Chien

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
Gigascience|December 22, 2017
VaDiR: an integrated approach to Variant Detection in RNALisa Neums, Seiji Suenaga, Peter Beyerlein, et al.
Pharmacogenomics|November 12, 2015
Molecular determinants of chemotherapy resistance in ovarian cancerMegan Cooley, Pingping Fang, Fang Fang, et al.
Molecular Cancer Research : MCR|March 17, 2018
Olaparib-induced Adaptive Response Is Disrupted by FOXM1 Targeting that Enhances Sensitivity to PARP InhibitionPingping Fang, Jill A Madden, Lisa Neums, et al.
Scientific Reports|February 8, 2018
Quinacrine upregulates p21/p27 independent of p53 through autophagy-mediated downregulation of p62-Skp2 axis in ovarian cancerDeokBeom Jung, Ashwani Khurana, Debarshi Roy, et al.
Pediatric Hematology and Oncology|April 22, 2024
Therapeutic efficacy of RAS inhibitor trametinib using a juvenile myelomonocytic leukemia patient-derived xenograft modelAlex Q Lee, Hiroaki Konishi, Masami Ijiri, et al.
Frontiers in Oncology|October 22, 2019
Coiled-Coil and C2 Domain-Containing Protein 1A (CC2D1A) Promotes Chemotherapy Resistance in Ovarian CancerSanjeev Kumar, Derek B Oien, Ashwani Khurana, et al.
BMC Genomics|April 2, 2020
A large-scale comparative study of isoform expressions measured on four platformsWei Zhang, Raphael Petegrosso, Jae-Woong Chang, et al.
Oncotarget|November 27, 2014
Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cellsXuan Zhang, Lihua Cheng, Kay Minn, et al.
Cells|May 14, 2022
Targeting Epigenetic Modifiers of Tumor Plasticity and Cancer Stem Cell BehaviorVigneshwari Easwar Kumar, Roshni Nambiar, Cristabelle De Souza, et al.
Cancer Research|June 17, 2006
HSulf-1 inhibits angiogenesis and tumorigenesis in vivoKeishi Narita, Julie Staub, Jeremy Chien, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Gigascience|December 22, 2017
VaDiR: an integrated approach to Variant Detection in RNALisa Neums, Seiji Suenaga, Peter Beyerlein, et al.
Pharmacogenomics|November 12, 2015
Molecular determinants of chemotherapy resistance in ovarian cancerMegan Cooley, Pingping Fang, Fang Fang, et al.
Molecular Cancer Research : MCR|March 17, 2018
Olaparib-induced Adaptive Response Is Disrupted by FOXM1 Targeting that Enhances Sensitivity to PARP InhibitionPingping Fang, Jill A Madden, Lisa Neums, et al.
Scientific Reports|February 8, 2018
Quinacrine upregulates p21/p27 independent of p53 through autophagy-mediated downregulation of p62-Skp2 axis in ovarian cancerDeokBeom Jung, Ashwani Khurana, Debarshi Roy, et al.
Pediatric Hematology and Oncology|April 22, 2024
Therapeutic efficacy of RAS inhibitor trametinib using a juvenile myelomonocytic leukemia patient-derived xenograft modelAlex Q Lee, Hiroaki Konishi, Masami Ijiri, et al.
Frontiers in Oncology|October 22, 2019
Coiled-Coil and C2 Domain-Containing Protein 1A (CC2D1A) Promotes Chemotherapy Resistance in Ovarian CancerSanjeev Kumar, Derek B Oien, Ashwani Khurana, et al.
BMC Genomics|April 2, 2020
A large-scale comparative study of isoform expressions measured on four platformsWei Zhang, Raphael Petegrosso, Jae-Woong Chang, et al.
Oncotarget|November 27, 2014
Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cellsXuan Zhang, Lihua Cheng, Kay Minn, et al.
Cells|May 14, 2022
Targeting Epigenetic Modifiers of Tumor Plasticity and Cancer Stem Cell BehaviorVigneshwari Easwar Kumar, Roshni Nambiar, Cristabelle De Souza, et al.
Cancer Research|June 17, 2006
HSulf-1 inhibits angiogenesis and tumorigenesis in vivoKeishi Narita, Julie Staub, Jeremy Chien, et al.
Pageof 10